| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.23 | 0.0002 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |